Hyperion Defi, Inc. (HYPD) Stock Price & Analysis
Hyperion Defi, Inc. (HYPD) fell 11.60% to USD 2.59 as of June 10, 2026 at 06:25 UTC, according to Nexqual real-time market data.
HYPD last closed at USD 2.93; the session ranged USD 2.56–2.92 on volume of 784,883 shares. Market capitalization is $39.26M, with a 52-week range of USD 2.11–17.18 (NCM). Source: Nexqual, June 10, 2026 at 06:25 UTC.
Key Statistics (as of June 10, 2026 at 06:25 UTC)
| Price | USD 2.59 |
|---|---|
| Change | ▼ 11.60% (down) |
| Previous Close | USD 2.93 |
| Open | USD 2.9 |
| Day Range | USD 2.56 – 2.92 |
| 52-Week Range | USD 2.11 – 17.18 |
| Volume | 784,883 shares |
| Market Cap | $39.26M |
| Exchange | NCM |
Technical Analysis (HYPD)
Nexqual's technical model rates HYPD "SELL" based on 1 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 06:25 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 36.99 (neutral) |
| vs SMA50 | Below (USD 3.68) |
| MACD | -0.13 (negative) |
Analyst Ratings (HYPD)
Wall Street analysts rate HYPD "Strong Buy" based on 2 analysts, with a mean price target of USD 5.65 (range USD 4–7.3), per Nexqual as of June 10, 2026 at 06:25 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 5.65 |
| High Target | USD 7.3 |
| Low Target | USD 4 |
| Buy / Hold / Sell | 2 / 0 / 0 |
Earnings (HYPD)
| Next Earnings Date | 2026-08-13 |
|---|---|
| Revenue Estimate | $450,000 |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-12-31 | USD -6.29 vs est -4.62 ▼ miss |
Source: Nexqual, June 10, 2026 at 06:25 UTC.
Financials & Fundamentals (HYPD)
| Total Revenue | $1.04M |
|---|---|
| Revenue Growth (YoY) | +1559.50% |
| Gross Margin | +70.93% |
| Operating Margin | -2063.53% |
| Profit Margin | +0.00% |
| ROE | -135.26% |
| Debt / Equity | 15.51 |
| Current Ratio | 1.97 |
| Total Cash | $7.38M |
| Total Debt | $9.07M |
| Free Cash Flow | $-7.54M |
Source: Nexqual, June 10, 2026 at 06:25 UTC.
Financial Health Score (HYPD)
Nexqual rates Hyperion Defi, Inc.'s overall financial health "Weak" across five dimensions, as of June 10, 2026 at 06:25 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Strong — $7M cash vs $9M debt |
| Cash Flow | Weak — FCF negative: -$8M, burning cash |
| Efficiency | Critical — ROE -135%, ROA -33.8% |
Ownership (HYPD)
| Insider Ownership | +12.94% |
|---|---|
| Institutional Ownership | +11.03% |
| Shares Outstanding | 15.16M |
| Float | 10.03M |
| Short % of Float | +5.25% |
Source: Nexqual, June 10, 2026 at 06:25 UTC.
Leadership (HYPD)
Hyperion Defi, Inc. is led by Hyunsu Jung (age 28), CEO, Chief Investment Officer & Director, per Nexqual as of June 10, 2026 at 06:25 UTC.
| CEO, Chief Investment Officer & Director | Hyunsu Jung (age 28) |
|---|---|
| Chief Financial Officer and Treasurer | David Knox C.F.A. (age 35) |
Major Backers & Investors (HYPD)
Notable institutional backers of Hyperion Defi, Inc. include Lasry, Marc, Morgan Stanley, Redwood Wealth Management Group, LLC, according to Nexqual as of June 10, 2026 at 06:25 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Lasry, Marc | 1.58% |
| Morgan Stanley | 1.57% |
| Redwood Wealth Management Group, LLC | 1.21% |
| Jane Street Group, LLC | 0.85% |
| Renaissance Technologies | 0.76% |
| Citadel | 0.74% |
| Fidelity | 0.46% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 1.12% |
| BlackRock | 0.54% |
| Geode Capital | 0.51% |
Source: Nexqual, June 10, 2026 at 06:25 UTC.
From Hyperion Defi, Inc.'s Latest SEC 10-K Filing (filed 2026-03-30)
Key Strengths & Strategy (as disclosed to the SEC)
- Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid.
- It operates through two segments: Ophthalmic Technology and Digital Assets.
- The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem.
- It is also developing the Optejet User Filled Device to work with various topical ophthalmic liquids, including artificial tears and lens rewetting products.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CYPH | Cypherpunk Technologies Inc. | USD 0.68 | ▲ 30.17% |
| CRVS | Corvus Pharmaceuticals, Inc. | USD 11.17 | ▲ 0.45% |
| ADIL | Adial Pharmaceuticals, Inc | USD 2.13 | ▼ 3.62% |
| CLSDQ | Clearside Biomedical, Inc. | USD 0.31 | ▲ 0% |
| ETON | Eton Pharmaceuticals, Inc. | USD 30.53 | ▲ 4.81% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 06:25 UTC. This page is informational and not investment advice.